Ghrelin for the management of cachexia associated with cancer

The Cochrane Database of Systematic Reviews
Mahalaqua Nazli KhatibZahiruddin Quazi Syed

Abstract

Cancer sufferers are amongst the most malnourished of all the patient groups. Studies have shown that ghrelin, a gut hormone can be a potential therapeutic agent for cachexia (wasting syndrome) associated with cancer. A variety of mechanisms of action of ghrelin in people with cancer cachexia have been proposed. However, safety and efficacy of ghrelin for cancer-associated cachexia have not been systematically reviewed. The aim of this review was to assess whether ghrelin is associated with better food intake, body composition and survival than other options for adults with cancer cachexia. To assess the efficacy and safety of ghrelin in improving food intake, body composition and survival in people with cachexia associated with cancer. We searched CENTRAL, MEDLINE and Embase without language restrictions up to July 2017. We also searched for ongoing studies in trials registers, performed handsearching, checked bibliographic references of relevant articles and contacted authors and experts in the field to seek potentially relevant research. We applied no restrictions on language, date, or publication status. We included randomised controlled (parallel-group or cross-over) trials comparing ghrelin (any formulation or route of ad...Continue Reading

References

Aug 1, 1988·Annals of Surgery·J A Windsor, G L Hill
Feb 1, 1996·Hematology/oncology Clinics of North America·S Watanabe, E Bruera
Oct 12, 2000·Biochemical and Biophysical Research Communications·Y MasudaK Kangawa
Nov 1, 2000·Nature·M TschöpM L Heiman
Dec 20, 2000·FEBS Letters·K MoriK Nakao
Feb 13, 2001·Endocrinology·O GualilloF Casanueva
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·A M WrenS R Bloom
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Marco VolanteMauro Papotti
Mar 27, 2002·International Journal of Epidemiology·Diana R ElbourneAndy Vail
Jul 3, 2003·The Journal of Physiology·Kazunori FujinoMineko Fujimiya
Aug 28, 2003·Diabetes·Lucy F FaulconbridgeHarvey J Grill
Jun 8, 2004·Endocrine Reviews·Aart J van der LelyEzio Ghigo
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Nicola M NearyStephen R Bloom
Feb 17, 2005·The Journal of Clinical Endocrinology and Metabolism·Josè M GarciaMarco Marcelli
May 13, 2006·Clinical Medicine : Journal of the Royal College of Physicians of London·Grant D StewartKenneth C H Fearon
Jun 10, 2006·The American Journal of Clinical Nutrition·Kenneth C FearonUNKNOWN Cancer Cachexia Study Group
Jul 25, 2006·Physiology & Behavior·David E Cummings
Oct 13, 2006·Medical Hypotheses·Yildiz GuneyCengiz Kurtman
Jan 11, 2007·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·M D KlokM L Drent
May 19, 2007·Journal of Pain and Symptom Management·Saskia C C M TeunissenAlexander de Graeff
Sep 1, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Weizhen ZhangMichael W Mulholland
Jan 15, 2008·Results and Problems in Cell Differentiation·Masayasu Kojima, Kenji Kangawa
Apr 12, 2008·The American Journal of Hospice & Palliative Care·Nabila Bennani-Baiti, Mellar P Davis
May 27, 2008·British Journal of Pharmacology·C P Velloso
Dec 9, 2008·Current Opinion in Supportive and Palliative Care·Nathan A StephensKenneth C H Fearon
Dec 26, 2008·JPEN. Journal of Parenteral and Enteral Nutrition·Federico Bozzetti, Luigi Mariani
Feb 7, 2009·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·José M Garcia, William J Polvino
Apr 4, 2009·Physiological Reviews·Michael J Tisdale
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Apr 29, 2010·Endocrine Journal·Keisuke SuzukiStephen R Bloom
Feb 8, 2011·The Lancet Oncology·Kenneth FearonVickie E Baracos
Apr 9, 2011·Journal of Cachexia, Sarcopenia and Muscle·Takashi Akamizu, Kenji Kangawa
Jul 19, 2011·Journal of Cachexia, Sarcopenia and Muscle·Vickie E Baracos
Nov 15, 2011·Recent Patents on Endocrine, Metabolic & Immune Drug Discovery·Carola LedderoseAndres Beiras-Fernandez
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Joanne ReidMichael Donnelly

❮ Previous
Next ❯

Citations

May 1, 2019·Brazilian Oral Research·Marjan NokhbehsaimJames Deschner
Nov 5, 2019·Frontiers in Oncology·Saeed Soleyman-JahiKazem Zendehdel
Aug 23, 2020·International Journal of Molecular Sciences·Cecilia T de BarrosMarco V Chaud
Jan 10, 2019·World Journal of Gastrointestinal Surgery·Anastasiya YakovenkoJose Gilberto Trevino
Mar 16, 2021·Journal of Cancer Research and Clinical Oncology·Alan J KimGoldy C George

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

The Cochrane Database of Systematic Reviews
Mia Schmidt-HansenJennifer S Hilgart
The Cochrane Database of Systematic Reviews
Anthony K AkobengMorris Gordon
The Cochrane Database of Systematic Reviews
Tess E CooperPhilip J Wiffen
The Cochrane Database of Systematic Reviews
Xiang Yong HaoYan Fei Shen
The Cochrane Database of Systematic Reviews
Helen GaskellCathy Stannard
© 2022 Meta ULC. All rights reserved